Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.
| Image |  |
|---|---|
| Description | scientific article published on 11 October 2017 |
| Author/s |
author: Georgina V. Long Andrew S Brohl Allison Betof Warner Alexander M Menzies |
| Publication date | January 1, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |